Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester

Documents similaires

• Correction to “Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester”
  Publié: (2026)
• Clarithromycin Use in the First Trimester Is Not Associated With Fetal Abnormalities
  par: Tomo Suzuki, et autres
  Publié: (2026)
• Risk of major birth defects after first‐trimester exposure to carbocisteine and ambroxol: A multicenter prospective cohort study using counseling data for drug safety during pregnancy
  par: Mariko Usuda, et autres
  Publié: (2024)
• A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan
  par: Mariko Honma, et autres
  Publié: (2024)
• Compound heterozygous ZNF335 variants in a patient with microcephaly, refractory epilepsy, and severe developmental delay: A case report and literature review
  par: Kaori Yamoto, et autres
  Publié: (2025)